Steven M. Paul - 01 Apr 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Reporting relationship: Director
Issuer ticker: ALNY
Reported as of: 01 Apr 2022
Net transaction value: -$2,390,421
SEC form: 4
Accepted by SEC: 05 Apr 2022, 16:05:01 UTC
Prior SEC filing: 17 Feb 2022
Next SEC filing: 17 Jun 2022
Source filing: View source filing
Reporting owner signature: By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Steven M. Paul

Key filing fact

Steven M. Paul filed Form 4 for ALNYLAM PHARMACEUTICALS, INC. (ALNY) on 05 Apr 2022.

Key facts

This page summarizes Steven M. Paul's Form 4 filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY).
12 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Apr 2022, 16:05.

Change

Previous filing in this sequence was filed on 17 Feb 2022.
Current net transaction value: -$2,390,421.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALNY transaction

Common Stock

Options Exercise

Transaction value: $169,950
Shares: +15,000
Change %: +1500%
Price: $11.33^*
Shares after: 16,000
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1

ALNY transaction

Common Stock

Sale

Transaction value: $42,008
Shares: -253
Change %: -1.6%
Price: $166.04
Shares after: 15,747
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F2

ALNY transaction

Common Stock

Sale

Transaction value: $835,965
Shares: -4,948
Change %: -31%
Price: $168.95
Shares after: 10,799
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F3

ALNY transaction

Common Stock

Sale

Transaction value: $826,827
Shares: -4,872
Change %: -45%
Price: $169.71
Shares after: 5,927
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F4

ALNY transaction

Common Stock

Sale

Transaction value: $211,383
Shares: -1,235
Change %: -21%
Price: $171.16
Shares after: 4,692
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F5

ALNY transaction

Common Stock

Sale

Transaction value: $246,791
Shares: -1,434
Change %: -31%
Price: $172.10
Shares after: 3,258
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F6

ALNY transaction

Common Stock

Sale

Transaction value: $111,105
Shares: -642
Change %: -20%
Price: $173.06
Shares after: 2,616
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F7

ALNY transaction

Common Stock

Sale

Transaction value: $15,690
Shares: -90
Change %: -3.4%
Price: $174.33
Shares after: 2,526
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1

ALNY transaction

Common Stock

Sale

Transaction value: $92,844
Shares: -526
Change %: -21%
Price: $176.51
Shares after: 2,000
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F8

ALNY transaction

Common Stock

Sale

Transaction value: $146,504
Shares: -825
Change %: -41%
Price: $177.58
Shares after: 1,175
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1, F9

ALNY transaction

Common Stock

Sale

Transaction value: $31,255
Shares: -175
Change %: -15%
Price: $178.60
Shares after: 1,000
Date: 01 Apr 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALNY transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -15,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 01 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $11.33
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 15,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.

Footnote F2

Sale prices ranged from $165.91 to $166.41.

Footnote F3

Sale prices ranged from $168.30 to $169.30.

Footnote F4

Sale prices ranged from $169.32 to $170.28.

Footnote F5

Sale prices ranged from $170.70 to $171.63.

Footnote F6

Sale prices ranged from $171.75 to $172.73.

Footnote F7

Sale prices ranged from $172.83 to $173.37.

Footnote F8

Sale prices ranged from $176.04 to $176.88.

Footnote F9

Sale prices ranged from $177.12 to $178.00.